BE372945A - - Google Patents
Info
- Publication number
- BE372945A BE372945A BE372945DA BE372945A BE 372945 A BE372945 A BE 372945A BE 372945D A BE372945D A BE 372945DA BE 372945 A BE372945 A BE 372945A
- Authority
- BE
- Belgium
- Prior art keywords
- urogenital system
- desc
- ray
- acids
- easily soluble
- Prior art date
Links
- 210000002229 urogenital system Anatomy 0.000 claims description 5
- 150000002896 organic halogen compounds Chemical class 0.000 claims description 2
- -1 dibromo-p-acetaminobenzoic acid Chemical compound 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- YFXWODPYUNGUEE-UHFFFAOYSA-N [I].[Li] Chemical compound [I].[Li] YFXWODPYUNGUEE-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002496 iodine Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE372945A true BE372945A (enEXAMPLES) |
Family
ID=43969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE372945D BE372945A (enEXAMPLES) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE372945A (enEXAMPLES) |
-
0
- BE BE372945D patent/BE372945A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH616080A5 (enEXAMPLES) | ||
| WO2008043911A2 (fr) | Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant | |
| EP2429590B1 (fr) | Procédé de préparation d'une formulation pharmaceutique de chélate de lanthanide | |
| DE1668930C3 (de) | Neue Alkylaminopropanole und ihre Salze mit Säuren, Verfahren zu ihrer Herstellung sowie therapeutische Mittel | |
| EP0354836B1 (fr) | Polymères iodés à squelette dextrane, leurs procédés de préparation et leurs applications comme produits de contraste | |
| BE372945A (enEXAMPLES) | ||
| DE3889644T2 (de) | Pheophorbidderivate. | |
| BE466916A (enEXAMPLES) | ||
| Bock et al. | Stereochemistry of phenyl pyrroles. XIX | |
| JPH07330773A (ja) | ポルフィリン誘導体とその用途 | |
| EP0465295A1 (fr) | Agent de contraste pour l'imagerie par RMN et agents chélateurs comportant des structures peptidiques | |
| EP0210091B1 (fr) | Procédé nouveau de réduction du pertechnétate | |
| AT129764B (de) | Verfahren zur Herstellung neuer wasserlöslicher Verbindungen der 2-Phenylchinolin-4-carbonsäure und ihrer Derivate. | |
| DD142653A5 (de) | Herstellungsmethode eines szintillographischen mittels | |
| BE424182A (enEXAMPLES) | ||
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| GB1569380A (en) | Pharmaceutical compositions comprising substituted phenyl-amino-alcohol and process for preparing these compositions | |
| DE1793399B (enEXAMPLES) | ||
| Brown | The Action of Salicylic Aldehyde on Sodium Pyrotartrate in Presence of Acetic Anhydride | |
| CH614696A5 (en) | Process for the preparation of phenol derivatives of hydroxyalkylalkylenediaminoacetic acids and their salts | |
| BE546149A (enEXAMPLES) | ||
| BE903568A (fr) | Nouveaux composes chimiques a activites antiphlogistiques, antiseptiques et detergentes | |
| BE723548A (enEXAMPLES) | ||
| BE382831A (enEXAMPLES) | ||
| FR2508044A1 (fr) | Acide 2',4'-difluoro-4-phosphonoxy (1,1'-diphenyle) - 3-carboxylique, sa preparation et son utilisation comme medicament |